ClinicalTrials.govpublic full text
Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov Approach
hematologic diseases, chronic myeloid leukemia, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 916202
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.